$3.11 Billion is the total value of Tekla Capital Management LLC's 171 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 59.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| UNH | Buy | Unitedhealth Group Inc. | $160,863,000 | +34.5% | 320,354 | +4.6% | 5.18% | +34.4% |
| MRNA | Buy | Moderna, Inc. | $138,832,000 | -21.5% | 546,624 | +19.0% | 4.47% | -21.5% |
| TMO | Buy | Thermo Fisher Scientific Inc. | $101,638,000 | +21.8% | 152,326 | +4.3% | 3.27% | +21.7% |
| ILMN | Buy | Illumina, Inc. | $86,060,000 | +9.4% | 226,212 | +16.6% | 2.77% | +9.3% |
| PFE | Buy | Pfizer Inc. | $69,201,000 | +257.2% | 1,171,903 | +160.2% | 2.23% | +256.9% |
| DHR | Buy | Danaher Corp. | $66,578,000 | +47.1% | 202,360 | +36.1% | 2.14% | +46.9% |
| SGEN | Buy | Seagen Inc. | $61,767,000 | +75.4% | 399,527 | +92.7% | 1.99% | +75.2% |
| SYK | Buy | Stryker Corp. | $49,093,000 | +23.7% | 183,582 | +22.0% | 1.58% | +23.6% |
| MCK | Buy | McKesson Corp. | $46,861,000 | +29.4% | 188,522 | +3.8% | 1.51% | +29.3% |
| BMY | Buy | Bristol-Myers Squibb Co. | $46,578,000 | +28.6% | 747,043 | +22.0% | 1.50% | +28.6% |
| SYNH | Buy | Syneos Health, Inc.class a | $41,389,000 | +94.2% | 403,087 | +65.4% | 1.33% | +94.2% |
| HUM | Buy | Humana Inc. | $32,312,000 | +56.3% | 69,660 | +31.1% | 1.04% | +56.2% |
| MOH | Buy | Molina Healthcare, Inc. | $31,275,000 | +37.8% | 98,325 | +17.6% | 1.01% | +37.6% |
| IQV | Buy | IQVIA Holdings Inc. | $27,693,000 | +50.8% | 98,154 | +28.1% | 0.89% | +50.8% |
| BNTX | Buy | BioNTech SEsponsored ads | $23,264,000 | +5.5% | 90,242 | +11.7% | 0.75% | +5.5% |
| BSX | Buy | Boston Scientific Corp. | $22,771,000 | +182.2% | 536,042 | +188.3% | 0.73% | +181.9% |
| ISRG | Buy | Intuitive Surgical, Inc. | $20,698,000 | +4.1% | 57,606 | +188.0% | 0.67% | +4.1% |
| RMD | Buy | ResMed Inc. | $19,432,000 | +419.6% | 74,599 | +425.8% | 0.62% | +420.8% |
| ARNA | Buy | Arena Pharmaceuticals, Inc. | $16,355,000 | +228.4% | 175,976 | +110.4% | 0.53% | +228.8% |
| JAZZ | Buy | Jazz Pharmaceuticals plcshares | $14,946,000 | +0.6% | 117,315 | +2.9% | 0.48% | +0.6% |
| NVO | Buy | Novo Nordisk A/Ssponsored adr | $13,255,000 | +44.3% | 118,349 | +23.7% | 0.43% | +44.3% |
| QURE | Buy | uniQure N.V.shares | $10,820,000 | +42.6% | 521,693 | +120.1% | 0.35% | +42.6% |
| AMN | New | AMN Healthcare Services, Inc. | $7,487,000 | – | 61,201 | +100.0% | 0.24% | – |
| CYTK | New | Cytokinetics, Inc. | $4,233,000 | – | 92,871 | +100.0% | 0.14% | – |
| PTGX | Buy | Protagonist Therapeutics, Inc. | $3,455,000 | +126.1% | 101,037 | +17.2% | 0.11% | +126.5% |
| ZLAB | Buy | Zai Lab Ltd.adr | $2,721,000 | -31.2% | 43,300 | +15.4% | 0.09% | -30.7% |
| ACAD | New | ACADIA Pharmaceuticals Inc. | $1,686,000 | – | 72,225 | +100.0% | 0.05% | – |
| DTIL | Buy | Precision BioSciences, Inc. | $1,662,000 | +128.6% | 224,534 | +256.4% | 0.05% | +130.4% |
| New | Pyxis Oncology, Inc. | $1,481,000 | – | 135,000 | +100.0% | 0.05% | – | |
| ALXO | Buy | ALX Oncology Holdings Inc. | $1,423,000 | +171.6% | 66,211 | +832.7% | 0.05% | +170.6% |
| New | Astellas Pharma Inc. | $1,445,000 | – | 88,837 | +100.0% | 0.05% | – | |
| DSGN | New | Design Therapeutics, Inc. | $1,399,000 | – | 65,351 | +100.0% | 0.04% | – |
| FULC | Buy | Fulcrum Therapeutics, Inc. | $1,367,000 | +10.4% | 77,293 | +76.1% | 0.04% | +10.0% |
| MRUS | New | Merus N.V. | $1,331,000 | – | 41,857 | +100.0% | 0.04% | – |
| CERE | New | Cerevel Therapeutics Holdings, Inc. | $1,329,000 | – | 41,003 | +100.0% | 0.04% | – |
| New | Theseus Pharmaceuticals, Inc. | $1,268,000 | – | 100,000 | +100.0% | 0.04% | – | |
| BEAM | New | Beam Therapeutics Inc. | $1,260,000 | – | 15,817 | +100.0% | 0.04% | – |
| ACET | New | Adicet Bio, Inc. | $1,108,000 | – | 63,329 | +100.0% | 0.04% | – |
| EWTX | New | Edgewise Therapeutics, Inc. | $925,000 | – | 60,550 | +100.0% | 0.03% | – |
| KOD | New | Kodiak Sciences Inc. | $723,000 | – | 8,530 | +100.0% | 0.02% | – |
| RPTX | New | Repare Therapeutics Inc. | $615,000 | – | 29,150 | +100.0% | 0.02% | – |
| IDYA | New | IDEAYA Biosciences, Inc. | $484,000 | – | 20,454 | +100.0% | 0.02% | – |
| New | Nexgel | $11,000 | – | 4,243 | +100.0% | 0.00% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Gilead Sciences, Inc. | 41 | Q2 2023 | 12.4% |
| Amgen, Inc. | 41 | Q2 2023 | 5.8% |
| Biogen Inc. | 41 | Q2 2023 | 6.5% |
| Vertex Pharmaceuticals Incorporated | 41 | Q2 2023 | 5.3% |
| Regeneron Pharmaceuticals, Inc. | 41 | Q2 2023 | 9.1% |
| Illumina, Inc. | 41 | Q2 2023 | 3.4% |
| BioMarin Pharmaceutical Inc. | 41 | Q2 2023 | 2.9% |
| Teva Pharmaceutical Industries Ltd. | 41 | Q2 2023 | 3.2% |
| Neurocrine Biosciences, Inc. | 41 | Q2 2023 | 1.4% |
| McKesson Corporation | 41 | Q2 2023 | 2.2% |
View Tekla Capital Management LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Rallybio Corp | January 23, 2023 | 1,727,067 | 4.6% |
| Zyla Life SciencesSold out | January 29, 2021 | 0 | 0.0% |
| ARCA biopharma, Inc. | January 24, 2020 | 36,068 | 2.3% |
| Verona Pharma plc | February 12, 2019 | 5,296,845 | 4.9% |
| Alliqua BioMedical, Inc. | February 12, 2018 | 165,000 | 3.3% |
| PIERIS PHARMACEUTICALS, INC. | February 12, 2018 | 1,962,380 | 4.4% |
| Intellipharmaceutics International Inc. | February 13, 2015 | 2,184,000 | 9.0% |
| HERON THERAPEUTICS, INC. /DE/ | February 14, 2014 | 20,598,613 | 4.2% |
| MEDWAVE INC | February 14, 2012 | 1,277,372 | 9.8% |
| MZT Holdings, Inc. | February 14, 2012 | 2,553,420 | 4.0% |
View Tekla Capital Management LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2023-08-10 |
| 13F-HR | 2023-05-10 |
| 13F-HR | 2023-02-10 |
| SC 13G/A | 2023-01-23 |
| 13F-HR | 2022-11-01 |
| 13F-HR | 2022-07-29 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-14 |
| SC 13G | 2022-01-21 |
| 13F-HR | 2021-11-12 |
View Tekla Capital Management LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.